← Eichor
Study identifier: NCT07318610 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

Condition: Peripheral Artery Disease (PAD)  ·  Sponsor: Regeneron Pharmaceuticals

PhasePhase 3
Planned participants7050
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is researching 2 different experimental drugs called REGN7508 and REGN9933. The study is focused on people who have Peripheral Artery Disease (PAD), which means that the blood vessels in their arms and legs have become too narrow. People with PAD have a higher risk of getting blood clots after procedures like Lower Extremity Revascularization (LER), a procedure to improve blood flow in the legs and feet. The aim of this study is to see how well REGN7508 and REGN9933 prevent life-threatening blood clots in participants with PAD who have recently had LER. The effects of REGN7508 and REGN9933, individually, will also be compared to rivaroxaban and a placebo. The study is looking at several other research questions, including: * What side effects might happen from taking the study drugs and how do they compare to the side effects of rivaroxaban * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drugs (which could make the drugs less effective or could lead to side effects) * If the study drugs affect the ability of the blood to clot normally

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trials Administrator  ·  844-734-6643  ·  clinicaltrials@regeneron.com

Always discuss trial participation with your own doctor first.

Locations (9)

Lake Martin Medical and Vascular CenterAlexander City, Alabama, United StatesRecruiting
Axsendo Clinical Research, Integrated Medical ServicesAvondale, Arizona, United StatesRecruiting
Applied Research Center of ArkansasLittle Rock, Arkansas, United StatesRecruiting
Nature Coast Clinical Research - CardiologyCrystal River, Florida, United StatesRecruiting
Cardiovascular SolutionsShreveport, Louisiana, United StatesRecruiting
Apex Research Foundation, LLCJackson, Tennessee, United StatesRecruiting
PharmaTex ResearchAmarillo, Texas, United StatesRecruiting
Epic Medical ResearchDeSoto, Texas, United StatesRecruiting
Epic Medical Research-PlanoPlano, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07318610